American Trust’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-558
Closed -$217K 338
2025
Q2
$217K Sell
558
-69
-11% -$27.8K 0.02% 268
2025
Q1
$273K Buy
627
+69
+12% +$27.7K 0.07% 107
2024
Q4
$206K Sell
558
-185
-25% -$77.4K 0.02% 299
2024
Q3
$386K Sell
743
-15
-2% -$8.01K 0.03% 152
2024
Q2
$411K Sell
758
-17
-2% -$8.99K 0.03% 143
2024
Q1
$402K Buy
775
+20
+3% +$9.95K 0.03% 157
2023
Q4
$356K Sell
755
-10
-1% -$4.62K 0.03% 182
2023
Q3
$333K Sell
765
-142
-16% -$64.4K 0.03% 198
2023
Q2
$403K Sell
907
-40
-4% -$18.5K 0.03% 240
2023
Q1
$435K Buy
947
+30
+3% +$14.3K 0.03% 233
2022
Q4
$470K Sell
917
-111
-11% -$56.4K 0.04% 222
2022
Q3
$467K Sell
1,028
-20
-2% -$9.57K 0.04% 202
2022
Q2
$505K Buy
1,048
+60
+6% +$29.7K 0.04% 212
2022
Q1
$486K Sell
988
-58
-6% -$26.5K 0.03% 252
2021
Q4
$485K Buy
+1,046
New +$440K 0.04% 167

Other funds holding ELV

American Trust's ELV Position: Q3 2025 in Review

American Trust sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 558 shares — an estimated $217K sold.

American Trust first reported a position in ELV in Q4 2021 and held it in 15 quarters. The position peaked at $505K in Q2 2022. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • American Trust reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • American Trust sold 558 Elevance Health shares in Q3 2025, an estimated $217K.
  • American Trust first reported a position in Elevance Health in Q4 2021 and held it in 15 quarters.
  • American Trust's Elevance Health position peaked at $505K in Q2 2022.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on American Trust's 13F filing for Q3 2025, filed 17 Nov 2025.